Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

by | Oct 17, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to …

FEATURED